Pricing the Pharmaceuticals When the Ability to Pay Differs : Taking Vertical Equity Seriously
Year of publication: |
2020
|
---|---|
Authors: | Kanniainen, Vesa |
Other Persons: | Laine, Juha (contributor) ; Linnosmaa, Ismo (contributor) |
Publisher: |
[2020]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Theorie | Theory |
Extent: | 1 Online-Ressource (29 p) |
---|---|
Series: | CESifo Working Paper ; No. 8031 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments 2019 erstellt |
Other identifiers: | 10.2139/ssrn.3523535 [DOI] |
Classification: | L10 - Market Structure, Firm Strategy, and Market Performance. General ; L50 - Regulation and Industrial Policy. General |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Pricing the pharmaceuticals when the ability to pay differs : taking vertical equity seriously
Kanniainen, Vesa, (2019)
-
Pharmaceutical regulation and health policy objectives
Birg, Laura, (2013)
-
Pharmaceutical Regulation and Health Policy Objectives
Birg, Laura, (2014)
- More ...
-
Pricing the Pharmaceuticals when the Ability to Pay Differs: Taking Vertical Equity Seriously.
Kanniainen, Vesa, (2019)
-
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa, (2021)
-
Efficient pricing and insurance coverage in pharmaceutical industry when the ability to pay matters
Kanniainen, Vesa, (2013)
- More ...